A
Adam S. Garden
Researcher at University of Texas MD Anderson Cancer Center
Publications - 564
Citations - 29069
Adam S. Garden is an academic researcher from University of Texas MD Anderson Cancer Center. The author has contributed to research in topics: Radiation therapy & Cancer. The author has an hindex of 81, co-authored 538 publications receiving 25511 citations. Previous affiliations of Adam S. Garden include University of Texas Health Science Center at Houston & Johns Hopkins University.
Papers
More filters
Journal ArticleDOI
A radiation therapy oncology group (RTOG) phase III randomized study to compare hyperfractionation and two variants of accelerated fractionation to standard fractionation radiotherapy for head and neck squamous cell carcinomas: first report of RTOG 9003
Karen K. Fu,Thomas F. Pajak,Andy Trotti,Christopher U. Jones,Sharon A. Spencer,Theodore L. Phillips,Adam S. Garden,John A. Ridge,Jay S. Cooper,K. Kian Ang +9 more
TL;DR: Hyperfractionation and accelerated fractionation with concomitant boost are more efficacious than standard fractionation for locally advanced head and neck cancer.
Journal ArticleDOI
Factors Associated With Severe Late Toxicity After Concurrent Chemoradiation for Locally Advanced Head and Neck Cancer: An RTOG Analysis
Mitchell Machtay,Jennifer Moughan,Andrew Trotti,Adam S. Garden,Randal S. Weber,Jay S. Cooper,Arlene A. Forastiere,K. Kian Ang +7 more
TL;DR: Older age, advanced T-stage, and larynx/hypopharynx primary site were strong independent risk factors and neck dissection after CCRT was associated with an increased risk of these complications.
Journal ArticleDOI
Quantification of volumetric and geometric changes occurring during fractionated radiotherapy for head-and-neck cancer using an integrated CT/linear accelerator system.
Jerry L. Barker,Adam S. Garden,K. Kian Ang,Jennifer O'Daniel,He Wang,Laurence E. Court,William H. Morrison,David I. Rosenthal,K.S.Clifford Chao,Susan L. Tucker,Radhe Mohan,Lei Dong +11 more
TL;DR: Measurable anatomic changes occurred throughout fractionated external beam RT for head-and-neck cancers, and these changes in the external contour, shape, and location of the target and critical structures appeared to be significant during the second half of treatment (after 3-4 weeks of treatment) and could have potential dosimetric impact when highly conformal treatment techniques are used.
Journal ArticleDOI
Validation of an accelerated 'demons' algorithm for deformable image registration in radiation therapy.
He Wang,Lei Dong,Jennifer O'Daniel,Radhe Mohan,Adam S. Garden,K. Kian Ang,Deborah A. Kuban,M. Bonnen,Joe Y. Chang,Rex Cheung +9 more
TL;DR: The results suggest that the accelerated demons algorithm has significant potential for delineating and tracking doses in targets and critical structures during CT-guided radiotherapy.
Journal ArticleDOI
Randomized Phase III Trial of Concurrent Accelerated Radiation Plus Cisplatin With or Without Cetuximab for Stage III to IV Head and Neck Carcinoma: RTOG 0522
K. Kian Ang,Qiang Zhang,David I. Rosenthal,Phuc Felix Nguyen-Tan,Eric J. Sherman,Randal S. Weber,James M. Galvin,James A. Bonner,Jonathan Harris,Adel K. El-Naggar,Maura L. Gillison,Richard C.K. Jordan,Andre Konski,Wade L. Thorstad,Andy Trotti,Jonathan J. Beitler,Adam S. Garden,William J. Spanos,Sue S. Yom,Rita Axelrod +19 more
TL;DR: Adding cetuximab to radiation-cisplatin did not improve outcome and hence should not be prescribed routinely, and the PFS and OS were higher in patients with p16-positive OPC, but outcomes did not differ by EGFR expression.